Skip to main content
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd — Investor Relations & Filings

Listed IPO Jun 2020
Ticker · BNR ISIN · US12233L1070 US Professional, scientific and technical activities
Filings indexed 163 across all filing types
Latest filing 2025-04-29 Annual Report
Country US United States of America
Listing US BNR · 1 venue

About Burning Rock Biotech Ltd

https://www.brbiotech.com/

Burning Rock Biotech Ltd. is a global diagnostics company specializing in precision oncology. The company focuses on applying next-generation sequencing (NGS) technology to develop and commercialize solutions for cancer diagnostics. Its portfolio includes NGS-based assays for both tissue and liquid biopsies, designed for cancer therapy selection and early detection. Burning Rock offers solutions covering the entire precision oncology development cycle, supported by an in-house database to facilitate clinical trials and research.

Recent filings

Filing Released Lang Actions
FORM 20-F
Annual Report FY 2024
2025-04-29 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes a press release as Exhibit 99.1 and is signed by the CEO. The document length is only 1653 characters, indicating it is a brief report rather than a full financial report. Form 6-K filings typically provide current information but do not contain comprehensive financial statements like annual or quarterly reports. Given the short length and nature of the filing, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-03-25 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1165 characters), and it primarily serves as a regulatory filing to report current information rather than a full financial report or announcement of voting results, management changes, or other specific categories. Therefore, it fits best under the Regulatory Filings (RNS) category, which is the fallback for miscellaneous filings that do not fit other specific categories.
2024-12-31 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It is for the month of December 2024 and includes a press release as Exhibit 99.1. The document is relatively short (1658 characters) and does not contain detailed financial statements or substantive financial data. It mainly serves as a regulatory filing to report information to the SEC and investors. Form 6-K filings are typically classified under Regulatory Filings (RNS) as they are miscellaneous reports that do not fit into other specific categories like Annual Reports or Earnings Releases. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-12-04 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC under the Securities Exchange Act of 1934. It includes an exhibit index listing a press release, notice of Annual General Meeting, form of proxy, and voting card. The document length is short (1281 characters) and primarily serves as a regulatory filing to report these materials. It does not contain detailed financial statements or substantive financial data, nor is it a full annual or interim report. It also does not represent a direct announcement of voting results or a proxy solicitation itself but includes notices related to the AGM. Given the nature and length, this is best classified as a Regulatory Filing (RNS) rather than the actual reports or presentations referenced.
2024-12-03 English
Regulatory Filings 2024
Regulatory Filings
2024-11-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.